Autosomal Dominant Polycystic Kidney: Clinical Trials

3 trials for Autosomal Dominant Polycystic Kidney, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3

Follow Autosomal Dominant Polycystic Kidney: new trials by email Literature Review of Autosomal Dominant Polycystic Kidney trials Research Report on Autosomal Dominant Polycystic Kidney

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Lixivaptan, Placebo - Autosomal Dominant Polycystic Kidney, ADPKD
Phase 3TerminatedPalladio Biosciences122021-10-282023-02-06
A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON
Bardoxolone methyl oral capsule, Placebo oral capsule - Autosomal Dominant Polycystic Kidney, ADPKD
Phase 3TerminatedBiogen6672019-05-292025-06-03
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
Bardoxolone methyl - Chronic Kidney Diseases, Alport Syndrome
Phase 3TerminatedBiogen2702019-03-082025-06-03

Narrower conditions

Polycystic Kidney, Autosomal Dominant (3)  ·  Nephritis, Hereditary (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Ciliopathies (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genetic Diseases, Inborn (3)  ·  Kidney Diseases (3)  ·  Kidney Diseases, Cystic (3)  ·  Male Urogenital Diseases (3)  ·  Polycystic Kidney Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Chronic Disease (1)  ·  Collagen Diseases (1)

Interventions

bardoxolone methyl (2)  ·  lixivaptan (1)

Sponsors

Biogen (2)  ·  Palladio Biosciences (1)

Countries

Australia (3)  ·  Spain (3)  ·  United States (3)  ·  France (2)  ·  Japan (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Turkey (Türkiye) (1)

Top investigators

Vicente Torres, MD, PhD (1)

Results publications

PMID 39356039

NIH funding

2018 (1)